Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Pisters

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Vascular Health and Risk Management|October 2, 2019
When to withhold oral anticoagulation in atrial fibrillation - an overview of frequent clinical discussion topicsJaap Seelig, Ron Pisters, Martin E Hemels, et al.
Thrombosis and Haemostasis|November 27, 2012
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart SurveyRon Pisters, Robby Nieuwlaat, Deirdre A Lane, et al.
Resuscitation Plus|February 20, 2026
Out-of-hospital cardiac arrest detection by a wearable: the first real-life caseRoos Edgar, Catharina E Jansen, Lente R Pol, et al.
Chest|September 19, 2009
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillationGregory Y H Lip, Robby Nieuwlaat, Ron Pisters, et al.
The American Journal of Medicine|May 20, 2014
Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart SurveyMaura Marcucci, Gregory Y H Lip, Robby Nieuwlaat, et al.
Journal of Vascular Surgery|June 17, 2022
Major adverse cardiac events after elective infrarenal endovascular aortic aneurysm repairEline Diender, Jenske J M Vermeulen, Ron Pisters, et al.
Chest|March 20, 2010
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart SurveyRon Pisters, Deirdre A Lane, Robby Nieuwlaat, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 28, 2013
Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trialRon Pisters, Stefan H Hohnloser, Stuart J Connolly, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 7, 2012
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart SurveyRon Pisters, Robby Nieuwlaat, Martin H Prins, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 18, 2011
Clinical and echocardiographic correlates of intra-atrial conduction delayBob Weijs, Cees B de Vos, Robert G Tieleman, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Vascular Health and Risk Management|October 2, 2019
When to withhold oral anticoagulation in atrial fibrillation - an overview of frequent clinical discussion topicsJaap Seelig, Ron Pisters, Martin E Hemels, et al.
Thrombosis and Haemostasis|November 27, 2012
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart SurveyRon Pisters, Robby Nieuwlaat, Deirdre A Lane, et al.
Resuscitation Plus|February 20, 2026
Out-of-hospital cardiac arrest detection by a wearable: the first real-life caseRoos Edgar, Catharina E Jansen, Lente R Pol, et al.
Chest|September 19, 2009
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillationGregory Y H Lip, Robby Nieuwlaat, Ron Pisters, et al.
The American Journal of Medicine|May 20, 2014
Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart SurveyMaura Marcucci, Gregory Y H Lip, Robby Nieuwlaat, et al.
Journal of Vascular Surgery|June 17, 2022
Major adverse cardiac events after elective infrarenal endovascular aortic aneurysm repairEline Diender, Jenske J M Vermeulen, Ron Pisters, et al.
Chest|March 20, 2010
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart SurveyRon Pisters, Deirdre A Lane, Robby Nieuwlaat, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 28, 2013
Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trialRon Pisters, Stefan H Hohnloser, Stuart J Connolly, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 7, 2012
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart SurveyRon Pisters, Robby Nieuwlaat, Martin H Prins, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 18, 2011
Clinical and echocardiographic correlates of intra-atrial conduction delayBob Weijs, Cees B de Vos, Robert G Tieleman, et al.
Pageof 8